Seema Malhotra Thekdi1, Kathrin Milbury2, Amy Spelman2, Qi Wei2, Christopher Wood3, Surena F Matin3, Nizar Tannir4, Eric Jonasch4, Louis Pisters3, Lorenzo Cohen2. 1. Department of Psychiatry, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 2. Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 3. Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 4. Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abstract
OBJECTIVE: The purpose of this study was to examine the prevalence of posttraumatic stress symptoms (PTSS) in patients with renal cell carcinoma (RCC), the associations and co-occurrence between PTSS, depressive, and other cancer-related symptoms and the ability of a single-item distress question to identify patients with PTSS. METHODS: Patients with stage I-IV RCC completed assessments of depressive symptoms (Center for Epidemiologic Studies Depression Scale), PTSS (Impact of Event Scale), cancer-related symptoms (MD Anderson Symptom Inventory), fatigue (Brief Fatigue Inventory), and sleep disturbance (Pittsburgh Sleep Quality Index). We used the distress item on the MD Anderson Symptom Inventory as a distress screener and general linear model analyses to test study hypotheses. RESULTS: Of the 287 patients (29% stage IV; 42% female; mean age = 58 years), 46% (n = 131) reported psychiatric symptoms with 15% (n = 44) reporting comorbid clinical levels of depressive symptoms and PTSS, 24% (n = 70) PTSS alone, and 6% (n = 17) depressive symptoms alone. Controlling for age, gender, and stage, patients with comorbid depressive symptoms and PTSS reported more cancer-related symptoms (p < 0.0001), fatigue (p < 0.0001), and sleep disturbance (p = 0.0003) than those with PTSS alone and more cancer-related symptoms (p = 0.002) and fatigue (p = 0.09) than those with depressive symptoms alone. Sensitivity analyses revealed that 26.9% of negative cases on the distress item fell within the clinical range of the Impact of Event Scale and 9.3% of negative cases met caseness on the Center for Epidemiologic Studies Depression Scale. CONCLUSIONS: Posttraumatic stress symptoms occurred both independently and comorbid with depressive symptoms in patients with RCC. PTSS were correlated with overall cancer symptom burden. Single-item distress screening was less sensitive in detecting PTSS than depressive symptoms. Therefore, additional screening strategies are required in the clinical setting.
OBJECTIVE: The purpose of this study was to examine the prevalence of posttraumatic stress symptoms (PTSS) in patients with renal cell carcinoma (RCC), the associations and co-occurrence between PTSS, depressive, and other cancer-related symptoms and the ability of a single-item distress question to identify patients with PTSS. METHODS:Patients with stage I-IV RCC completed assessments of depressive symptoms (Center for Epidemiologic Studies Depression Scale), PTSS (Impact of Event Scale), cancer-related symptoms (MD Anderson Symptom Inventory), fatigue (Brief Fatigue Inventory), and sleep disturbance (Pittsburgh Sleep Quality Index). We used the distress item on the MD Anderson Symptom Inventory as a distress screener and general linear model analyses to test study hypotheses. RESULTS: Of the 287 patients (29% stage IV; 42% female; mean age = 58 years), 46% (n = 131) reported psychiatric symptoms with 15% (n = 44) reporting comorbid clinical levels of depressive symptoms and PTSS, 24% (n = 70) PTSS alone, and 6% (n = 17) depressive symptoms alone. Controlling for age, gender, and stage, patients with comorbid depressive symptoms and PTSS reported more cancer-related symptoms (p < 0.0001), fatigue (p < 0.0001), and sleep disturbance (p = 0.0003) than those with PTSS alone and more cancer-related symptoms (p = 0.002) and fatigue (p = 0.09) than those with depressive symptoms alone. Sensitivity analyses revealed that 26.9% of negative cases on the distress item fell within the clinical range of the Impact of Event Scale and 9.3% of negative cases met caseness on the Center for Epidemiologic Studies Depression Scale. CONCLUSIONS:Posttraumatic stress symptoms occurred both independently and comorbid with depressive symptoms in patients with RCC. PTSS were correlated with overall cancer symptom burden. Single-item distress screening was less sensitive in detecting PTSS than depressive symptoms. Therefore, additional screening strategies are required in the clinical setting.
Authors: Bang-Ning Lee; Robert Dantzer; Keith E Langley; Gary J Bennett; Patrick M Dougherty; Adrian J Dunn; Christina A Meyers; Andrew H Miller; Richard Payne; James M Reuben; Xin Shelley Wang; Charles S Cleeland Journal: Neuroimmunomodulation Date: 2004 Impact factor: 2.492
Authors: Dale J Langford; Bruce Cooper; Steven Paul; Janice Humphreys; Carolyn Keagy; Yvette P Conley; Marilyn J Hammer; Jon D Levine; Fay Wright; Michelle Melisko; Christine Miaskowski; Laura B Dunn Journal: Health Psychol Date: 2017-08-21 Impact factor: 4.267
Authors: Tara Stacker; Kord M Kober; Laura Dunn; Carol Viele; Steven M Paul; Marilyn Hammer; Yvette P Conley; Jon D Levine; Christine Miaskowski Journal: Cancer Nurs Date: 2022-03-02 Impact factor: 2.760
Authors: Chelsea G Ratcliff; Kathrin Milbury; Kavita D Chandwani; Alejandro Chaoul; George Perkins; Raghuram Nagarathna; Robin Haddad; Hongasandra Ramarao Nagendra; N V Raghuram; Amy Spelman; Banu Arun; Qi Wei; Lorenzo Cohen Journal: Integr Cancer Ther Date: 2016-02-11 Impact factor: 3.279
Authors: Eva Van Gerven; Luk Bruyneel; Massimiliano Panella; Martin Euwema; Walter Sermeus; Kris Vanhaecht Journal: BMJ Open Date: 2016-08-31 Impact factor: 2.692